The Journal of Experimental Medicine
R&D Systems
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online March 12, 2007
doi:10.1084/jem.20061791
The Journal of Experimental Medicine, Vol. 204, No. 3, 481-487
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Perrigoue et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perrigoue, J. G.
Right arrow Articles by Artis, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perrigoue, J. G.
Right arrow Articles by Artis, D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

 IL-31–IL-31R interactions negatively regulate type 2 inflammation in the lung

Jacqueline G. Perrigoue1, Ji Li2, Colby Zaph1, Michael Goldschmidt1, Phillip Scott1, Frederic J. de Sauvage2, Edward J. Pearce1, Nico Ghilardi2, and David Artis1

1 Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104
2 Genentech, Inc., South San Francisco, CA 94080

CORRESPONDENCE David Artis: dartis{at}vet.upenn.edu OR Nico Ghilardi: ghilardi.nico{at}gene.com

Interleukin (IL) 31R{alpha} (glycoprotein 130–like monocyte receptor and glycoprotein 130–like receptor) heterodimerizes with oncostatin M receptor ß to bind IL-31, a cytokine expressed preferentially by CD4+ T helper type 2 (Th2) cells. However, the functions of IL-31–IL-31R signaling in immune regulation remain unknown. Here, we identify a novel role for IL-31R in limiting type 2 inflammation in the lung. After intravenous injection of Schistosoma mansoni eggs, IL-31R{alpha}–/– mice developed severe pulmonary inflammation, characterized by an increase in the area of granulomatous inflammation, increased numbers of resistin-like molecule {alpha}+ cells, and enhanced collagen deposition compared to WT counterparts. In vitro, macrophages generated from IL-31R{alpha}–/– mice promoted enhanced ovalbumin-specific CD4+ T cell proliferation and purified naive CD4+ T cells from IL-31R{alpha}–/– mice exhibited enhanced proliferation and expression of Th2 cytokines, identifying a T cell– and macrophage-intrinsic regulatory function for IL-31R signaling. In contrast, the generation of CD4+ T cell–mediated Th1 responses were normal in IL-31R{alpha}–/– mice, suggesting that the regulatory role of IL-31R signaling is limited to type 2 responses. Together, these data implicate IL-31R signaling as a novel negative regulatory pathway that specifically limits type 2 inflammation.

J.G. Perrigoue and J. Li contributed equally to this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS